Full metadata record
DC FieldValueLanguage
dc.contributor.authorDette, Holger-
dc.contributor.authorGuilbaud, Olivier-
dc.contributor.authorMiller, Frank-
dc.date.accessioned2007-07-13T12:15:30Z-
dc.date.available2007-07-13T12:15:30Z-
dc.date.issued2007-07-13T12:15:30Z-
dc.identifier.urihttp://hdl.handle.net/2003/24437-
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-14532-
dc.description.abstractWe consider a dose-finding trial in phase IIB of drug development. For choosing an appropriate design for this trial the specification of two points is critical: an appropriate model for describing the dose-effect relationship and the specification of the aims of the trial (objectives), which will be the focus in the present paper. For many practical situations it is essential to have a robust trial objective that has little risk of changing during the complete trial due to external information. An important and realistic objective of a dose-finding trial is to obtain precise information about the interesting part of the dose-effect curve. We reflect this goal in a statistical optimality criterion and derive efficient designs using optimal design theory. In particular we determine non-adaptive Bayesian optimal designs, i.e. designs which are not changed by information obtained from an interim analysis. Compared with a traditional balanced design for this trial it is shown that the optimal design is substantially more efficient. This implies either a gain in information or essential savings in sample size. Further, we investigate an adaptive Bayesian optimal design that uses two different optimal designs before and after an interim analysis, and we compare the adaptive with the non-adaptive Bayesian optimal design. The basic concept is illustrated using a modification of a recent AstraZeneca trial.en
dc.language.isoende
dc.subjectadaptive designen
dc.subjectBayesian designen
dc.subjectclinical trialen
dc.subjectdose-findingen
dc.subjectinteresting part of dose-effect curveen
dc.subjectoptimal designen
dc.subjectprior knowledgeen
dc.subjecttwo-stage designen
dc.subject.ddc004-
dc.titleOptimal designs for estimating the interesting part of a dose-effect curveen
dc.typeTextde
dc.type.publicationtypereporten
dcterms.accessRightsopen access-
Appears in Collections:Sonderforschungsbereich (SFB) 475

Files in This Item:
File Description SizeFormat 
tr21-07.pdfDNB337.22 kBAdobe PDFView/Open


This item is protected by original copyright



This item is protected by original copyright rightsstatements.org